It's not entirely clear how a move to a Schedule III substance could impact Pennsylvania, but there could be some benefits for the medical marijuana industry.More than five decades after it was first identified as a dangerous drug with no medical value and a high potential for abuse,
Such drugs are criminally prohibited at the federal level, cannot be prescribed for medical use, and aren’t easily medically researchable.No. As a Schedule III drug, marijuana would still be regulated by the DEA. State medical and recreational marijuana programs would also remain federally illegal once the change takes effect,
With cannabis as a Schedule III drug, Pennsylvania marijuana businesses could see a reduction in their federal tax burden, which can be 70% or more, according to industry groups. called rescheduling a “significant” step, but said it ultimately, it “fails to adequately address” the conflict between state and federal laws.